These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15884486)

  • 1. [Chronic obstructive pulmonary disease (COPD): expression of a chronic inflammatory reaction].
    Ziesche R
    Wien Med Wochenschr; 2005 Mar; 155(5-6):81-4. PubMed ID: 15884486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pathobiology of COPD].
    Pohl W
    Wien Med Wochenschr; 2005 Mar; 155(5-6):85-9. PubMed ID: 15884487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease.
    Sohal SS; Ward C; Danial W; Wood-Baker R; Walters EH
    Expert Rev Respir Med; 2013 Jun; 7(3):275-88. PubMed ID: 23734649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung.
    Tomaki M; Sugiura H; Koarai A; Komaki Y; Akita T; Matsumoto T; Nakanishi A; Ogawa H; Hattori T; Ichinose M
    Pulm Pharmacol Ther; 2007; 20(5):596-605. PubMed ID: 16919984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis of cigarette smoking-induced stable COPD.
    Caramori G; Kirkham P; Barczyk A; Di Stefano A; Adcock I
    Ann N Y Acad Sci; 2015 Mar; 1340():55-64. PubMed ID: 25639503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox.
    Eapen MS; Myers S; Walters EH; Sohal SS
    Expert Rev Respir Med; 2017 Oct; 11(10):827-839. PubMed ID: 28743228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction.
    Boehme SA; Franz-Bacon K; Ludka J; DiTirro DN; Ly TW; Bacon KB
    PLoS One; 2016; 11(12):e0167169. PubMed ID: 27935962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and free radicals in COPD--implications and relevance for treatment.
    Domej W; Oettl K; Renner W
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1207-24. PubMed ID: 25378921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
    Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
    Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis.
    Cappello F; Caramori G; Campanella C; Vicari C; Gnemmi I; Zanini A; Spanevello A; Capelli A; La Rocca G; Anzalone R; Bucchieri F; D'Anna SE; Ricciardolo FL; Brun P; Balbi B; Carone M; Zummo G; Conway de Macario E; Macario AJ; Di Stefano A
    PLoS One; 2011; 6(11):e28200. PubMed ID: 22140545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-150 protects against cigarette smoke-induced lung inflammation and airway epithelial cell apoptosis through repressing p53: MicroRNA-150 in CS-induced lung inflammation.
    Xue H; Li MX
    Hum Exp Toxicol; 2018 Sep; 37(9):920-928. PubMed ID: 29205062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New concepts in chronic obstructive pulmonary disease.
    Barnes PJ
    Annu Rev Med; 2003; 54():113-29. PubMed ID: 12359824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
    Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease.
    Seys LJ; Verhamme FM; Schinwald A; Hammad H; Cunoosamy DM; Bantsimba-Malanda C; Sabirsh A; McCall E; Flavell L; Herbst R; Provoost S; Lambrecht BN; Joos GF; Brusselle GG; Bracke KR
    Am J Respir Crit Care Med; 2015 Sep; 192(6):706-18. PubMed ID: 26266827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway inflammation in chronic obstructive pulmonary disease.
    Górska K; Maskey-Warzechowska M; Krenke R
    Curr Opin Pulm Med; 2010 Mar; 16(2):89-96. PubMed ID: 19904205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of chronic obstructive pulmonary disease.
    Barnes PJ
    Pharmacol Rev; 2004 Dec; 56(4):515-48. PubMed ID: 15602009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic inflammation in chronic obstructive pulmonary disease.
    Wouters EF
    Proc Am Thorac Soc; 2005; 2(1):26-33. PubMed ID: 16113466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of inhaled corticosteroids in chronic obstructive pulmonary disease: similarities and differences to asthma.
    Jeffery P
    Expert Opin Investig Drugs; 2005 May; 14(5):619-32. PubMed ID: 15926868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.
    Tashkin DP; Wechsler ME
    Int J Chron Obstruct Pulmon Dis; 2018; 13():335-349. PubMed ID: 29403271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.